Healthcare Value Capital, LLC Buys ProShares UltraPro Short S&P500, AstraZeneca PLC, Laboratory Corp of America Holdings, Sells Viking Therapeutics Inc, CVS Health Corp, Gilead Sciences Inc

• New Purchases: SPXU, AZN, LH, JAZZ, ALXN, MNLO, WBA,
• Added Positions: MCK, CAH, ABC, CLVS, ATRS, GNLN,
• Reduced Positions: CVS, GILD,
• Sold Out: VKTX, FOMX,

For the details of Healthcare Value Capital, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/healthcare+value+capital%2C+llc/current-portfolio/portfolio

1. AbbVie Inc (ABBV) - 50,000 shares, 6.41% of the total portfolio.
2. GlaxoSmithKline PLC (GSK) - 100,000 shares, 6.37% of the total portfolio.
3. Gilead Sciences Inc (GILD) - 50,000 shares, 6.29% of the total portfolio. Shares reduced by 28.57%
4. Gilead Sciences Inc (GILD) - 50,000 shares, 6.29% of the total portfolio.
5. ProShares UltraPro Short S&P500 (SPXU) - 150,000 shares, 6.09% of the total portfolio. New Position

Healthcare Value Capital, LLC initiated holding in ProShares UltraPro Short S&P500. The purchase prices were between $17.19 and $41.53, with an estimated average price of $22.03. The stock is now traded at around $16.04. The impact to a portfolio due to this purchase was 6.09%. The holding were 150,000 shares as of .

Healthcare Value Capital, LLC initiated holding in AstraZeneca PLC. The purchase prices were between $37.79 and $51.33, with an estimated average price of $47.19. The stock is now traded at around $53.50. The impact to a portfolio due to this purchase was 5.64%. The holding were 75,000 shares as of .

Healthcare Value Capital, LLC initiated holding in Laboratory Corp of America Holdings. The purchase prices were between $104.32 and $195.28, with an estimated average price of $168.3. The stock is now traded at around $163.75. The impact to a portfolio due to this purchase was 5.32%. The holding were 25,000 shares as of .

Healthcare Value Capital, LLC initiated holding in Jazz Pharmaceuticals PLC. The purchase prices were between $87.74 and $152.74, with an estimated average price of $130.11. The stock is now traded at around $108.80. The impact to a portfolio due to this purchase was 5.03%. The holding were 30,000 shares as of .

Healthcare Value Capital, LLC initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $75.56 and $113.92, with an estimated average price of $98.6. The stock is now traded at around $100.92. The impact to a portfolio due to this purchase was 4.53%. The holding were 30,000 shares as of .

Healthcare Value Capital, LLC initiated holding in Menlo Therapeutics Inc. The purchase prices were between $2.18 and $6.94, with an estimated average price of $4.41. The stock is now traded at around $1.71. The impact to a portfolio due to this purchase was 3.83%. The holding were 850,000 shares as of .

Healthcare Value Capital, LLC added to a holding in McKesson Corp by 150.00%. The purchase prices were between $115.75 and $170.96, with an estimated average price of $146.83. The stock is now traded at around $129.42. The impact to a portfolio due to this purchase was 3.41%. The holding were 25,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Cardinal Health Inc by 114.29%. The purchase prices were between $41 and $60.42, with an estimated average price of $52.05. The stock is now traded at around $47.30. The impact to a portfolio due to this purchase was 3.23%. The holding were 75,000 shares as of .

Healthcare Value Capital, LLC added to a holding in AmerisourceBergen Corp by 50.00%. The purchase prices were between $73.93 and $97, with an estimated average price of $88.21. The stock is now traded at around $84.03. The impact to a portfolio due to this purchase was 1.49%. The holding were 30,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Clovis Oncology Inc by 66.67%. The purchase prices were between $3.77 and $11, with an estimated average price of $8.11. The stock is now traded at around $9.50. The impact to a portfolio due to this purchase was 1.07%. The holding were 250,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Antares Pharma Inc by 66.67%. The purchase prices were between $1.75 and $4.7, with an estimated average price of $3.44. The stock is now traded at around $2.57. The impact to a portfolio due to this purchase was 0.79%. The holding were 500,000 shares as of .

Healthcare Value Capital, LLC added to a holding in Greenlane Holdings Inc by 28.57%. The purchase prices were between $1.21 and $3.42, with an estimated average price of $2.34. The stock is now traded at around $2.27. The impact to a portfolio due to this purchase was 0.14%. The holding were 225,000 shares as of .

Healthcare Value Capital, LLC sold out a holding in Viking Therapeutics Inc. The sale prices were between $3.45 and $8.02, with an estimated average price of $6.2.

Healthcare Value Capital, LLC sold out a holding in Foamix Pharmaceuticals Ltd. The sale prices were between $2.99 and $4.71, with an estimated average price of $3.99.